Navigation Links
New England Biolabs Develops Novel Small RNA NGS Protocol: Reagents Improve Yield and Decrease Adaptor-Dimer Formation
Date:2/2/2011

IPSWICH, Mass., Feb. 2, 2011 /PRNewswire/ -- New England Biolabs has expanded its line of reagents for sample preparation upstream of next generation sequencing to include NEBNext® Small RNA Sample Prep Set 1 for sequencing on the Illumina® platforms, and NEBNext Small RNA Sample Prep Set 3 for sequencing on LIFE's SOLiD™ platform. These new products offer a new and unique protocol, which results in higher yields and lower adaptor-dimer formation, as compared to other protocols. With oligos, enzymes and buffers included, both sets provide substantial cost savings, and the master mix format streamlines the workflow by reducing the number of vials and pipetting steps required.

(Photo: http://photos.prnewswire.com/prnh/20110202/NE41303 )

(Logo: http://www.newscom.com/cgi-bin/prnh/20090921/NE79207LOGO-b)

NEBNext products are a series of highly pure and cost-effective reagents that facilitate DNA and RNA sample preparation for downstream applications, such as next generation sequencing. NEBNext reagents are available for DNA, ChIP-Seq, mRNA and small RNA sample preparation. All reagents undergo stringent quality controls and functional validation by sequencing, ensuring maximum yield, convenience and value. Available as reagent sets, master mixes or modules for the three leading next generation sequencing platforms, the full range of NEBNext reagents offer convenience and customization of workflow.

For more information, visit www.NEBNext.com.

About NEB

Established in the mid 1970's, New England Biolabs, Inc. is the industry leader in the discovery and production of enzymes for molecular biology applications, and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, cellular analysis, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and five subsidiaries located in Canada, China, Germany, Japan and the UK. For more information about New England Biolabs, visit www.neb.com.

Illumina® is a registered trademark of Illumina, Inc.

SOLiD™ is a trademark of LIFE Technologies.


'/>"/>
SOURCE New England Biolabs
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. New England Peptide Names Director of Chemical Development
2. NeoStem Secures $250,000 in an Above Market Financing and Expands Its Relationship With New England Cryogenic Center, Inc.
3. New England Peptide Forms Scientific Advisory Board
4. Gene Therapy Field Advances With Important Clinical Findings Reported in the New England Journal of Medicine
5. New England Journal of Medicine Study Highlights Need for Rapid, PCR-based Group B Streptococcus (GBS) Testing at Time of Admission for Labor and Delivery
6. Data Published in The New England Journal of Medicine Support Use of Raxibacumab (ABthrax(TM)) for the Treatment of Inhalation Anthrax
7. First U.K. Stem Cell Awareness Rally to Take Place in Manchester, England on August 9th, 2009
8. Ontario Institute for Cancer Research Validates NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for use in Next Generation Sequencing
9. Wellcome Trust Sanger Institute to use NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for Next Generation Sequencing
10. Organogenesis CEO Geoff MacKay and COO / CFO Gary Gillheeney Named Ernst & Young Entrepreneur Of The Year(R) 2009 Award Winners in New England
11. New England Biolabs Launches NEBNext(TM) DNA Sample Prep Master Mix Set 3 for Use with SOLiD(TM) 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... ... June 19, 2017 , ... EDETEK, Inc., a clinical technology ... is launching two new additions of its award-winning cloud-based platform CONFORM™: Information Hub ... DIA 2017 Annual Meeting in Chicago, IL, June 19-22, 2017. , “Modern clinical ...
(Date:6/16/2017)... Massachusetts (PRWEB) , ... June 16, 2017 , ... ... medical device compliance and commercialization, has just announced two more sessions of its ... the series will focus on the world of online templates for design control ...
(Date:6/15/2017)... ... June 15, 2017 , ... New resistant soybean and ... for managing Palmer amaranth and other broadleaf weeds resistant to glyphosate. But scientists ... Auxin herbicides are known to drift and to cause harm to sensitive, off-target ...
(Date:6/15/2017)... ... June 15, 2017 , ... angelMD announced the closure ... Dan Parsley, angelMD’s SVP of Corporate Development, served as the syndicate leader for ... part of Saranas’ recently announced $4 million Series B financing round. , Saranas ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 Today HYPR Corp. , leading ... component of the HYPR platform is officially FIDO® ... security architecture that empowers biometric authentication across Fortune 500 ... secured over 15 million users across the financial services ... home product suites and physical access represent a growing ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/30/2017)... -- On April 6-7, 2017, Sequencing.com will host the world,s ... at Microsoft,s headquarters in Redmond, Washington ... health and wellness apps that provide a unique, personalized ... is the first hackathon for personal genomics and the ... the genomics, tech and health industries are sending teams ...
Breaking Biology News(10 mins):